Key Takeaways
- • RoundTable Healthcare Partners, a Lake Forest, Illinois-based private equity firm founded in 2001, announced a partnership and investment in Colorescience, Inc., a premium skincare and sun protection brand, in February 2026.
- • RoundTable operates as an operating-oriented private equity firm focused exclusively on the healthcare industry, leveraging extensive industry relationships and proven operating and transaction expertise to build value in portfolio companies.
- • The firm employs a partnership-driven strategy with healthcare companies, emphasizing long-term value creation through operational improvements and industry expertise rather than financial engineering alone.
- • RoundTable's investment approach attracts experienced healthcare executives; the firm has demonstrated ability to retain talent across multiple fund cycles, as evidenced by senior team members returning for subsequent investment periods.
Summary
RoundTable Healthcare Partners, an operating-oriented private equity firm headquartered in Lake Forest, Illinois, announced an investment partnership with Colorescience, Inc., a premium skincare and sun protection company. Founded in 2001, RoundTable has maintained a focused strategy of investing exclusively within the healthcare industry, distinguishing itself through operational expertise and deep industry relationships rather than purely financial optimization.
The firm's investment philosophy centers on creating value through active partnership with portfolio companies. RoundTable emphasizes its ability to provide portfolio companies with extensive operating expertise and proven transaction capabilities, positioning itself as a hands-on operator rather than a passive financial investor. This approach has enabled the firm to build long-term relationships with management teams; the firm has successfully retained senior executives across multiple fund cycles, demonstrating confidence in RoundTable's value-creation methodology.
Specific transaction terms for the Colorescience investment were not disclosed. The investment represents RoundTable's continued commitment to identifying and scaling healthcare-adjacent businesses—in this case, premium skincare and sun protection products—that align with its healthcare industry focus. The partnership with Colorescience underscores the firm's strategy of partnering with companies capable of benefiting from RoundTable's extensive industry relationships and operational expertise to achieve sustainable growth and market leadership within their respective segments.
The firm's investment philosophy centers on creating value through active partnership with portfolio companies. RoundTable emphasizes its ability to provide portfolio companies with extensive operating expertise and proven transaction capabilities, positioning itself as a hands-on operator rather than a passive financial investor. This approach has enabled the firm to build long-term relationships with management teams; the firm has successfully retained senior executives across multiple fund cycles, demonstrating confidence in RoundTable's value-creation methodology.
Specific transaction terms for the Colorescience investment were not disclosed. The investment represents RoundTable's continued commitment to identifying and scaling healthcare-adjacent businesses—in this case, premium skincare and sun protection products—that align with its healthcare industry focus. The partnership with Colorescience underscores the firm's strategy of partnering with companies capable of benefiting from RoundTable's extensive industry relationships and operational expertise to achieve sustainable growth and market leadership within their respective segments.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.